Effects of the glucose-lowering rate on cTnI and hs-CRP serum levels in type 2 diabetics

The glucose-lowering rate in T2DM+CHD group should be no more than 4 mmol L−1 d−1 and the appropriate glucose-lowering rate in T2DM group is no more than 6 mmol L−1 d−1. Serum levels of cTnI and hs-CRP will be increased if the glucose-lowering rate is over this range, which means that cardiovascular endpoints might be induced.